Hoffman, Kim A. http://orcid.org/0000-0003-3063-7881
Baker, Robin
Kunkel, Lynn E.
Waddell, Elizabeth Needham
Lum, Paula J.
McCarty, Dennis
Korthuis, P. Todd
Article History
Received: 17 April 2019
Accepted: 7 November 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: All of the authors are co-investigators on CTN-0067. Alkermes (a global biopharmaceutical company) has donated the extended-release naltrexone used in the study protocol. In addition, Dr. Korthuis serves on a separate investigation using buprenorphine donated by Indivior. Dr. Kim Hoffman is an associated editor for BMC Health Services Research. The remaining authors declare no competing interests.